Deepika Rathna Murugesan

Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months

Guruprasad R. Medigeshi, Gaurav Batra, Deepika Rathna Murugesan et al. · EBioMedicine · 2022 · 58 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation

Akshay Binayke, Aymaan Zaheer, Siddhesh Vishwakarma et al. · npj Vaccines · 2024 · 26 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Clinical and experimental evidence suggest omicron variant of SARS-CoV-2 is inherently less pathogenic than delta variant independent of previous immunity

Ramachandran Thiruvengadam, Zaigham Abbas Rizvi, Sreevatsan Raghavan et al. · European journal of medical research · 2023 · 21 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Incidence of and risk factors for small vulnerable newborns in north India: a secondary analysis of a prospective pregnancy cohort

Ramachandran Thiruvengadam, Ayushi Ayushi, Deepika Rathna Murugesan et al. · The Lancet Global Health · 2024 · 15 citations · Full text

Public Health, Maternal Health, Obstetrics +17

Sub-optimal Neutralisation of Omicron (B.1.1.529) Variant by Antibodies induced by Vaccine alone or SARS-CoV-2 Infection plus Vaccine (Hybrid Immunity) post 6-months

Guruprasad R. Medigeshi, Gaurav Batra, Deepika Rathna Murugesan et al. · medRxiv · 2022 · 11 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17